778 related articles for article (PubMed ID: 1934265)
1. Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon.
Turesky RJ; Lang NP; Butler MA; Teitel CH; Kadlubar FF
Carcinogenesis; 1991 Oct; 12(10):1839-45. PubMed ID: 1934265
[TBL] [Abstract][Full Text] [Related]
2. Glucuronidation of N-hydroxy heterocyclic amines by human and rat liver microsomes.
Kaderlik KR; Mulder GJ; Turesky RJ; Lang NP; Teitel CH; Chiarelli MP; Kadlubar FF
Carcinogenesis; 1994 Aug; 15(8):1695-701. PubMed ID: 8055651
[TBL] [Abstract][Full Text] [Related]
3. Metabolic processing and disposition of 2-amino-3-methylimidazo[4,5-f] quinoline (IQ), 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx), and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in nonhuman primates.
Snyderwine EG; Turesky RJ; Buonarati MH; Turteltaub KW; Adamson RH
Princess Takamatsu Symp; 1995; 23():69-77. PubMed ID: 8844797
[TBL] [Abstract][Full Text] [Related]
4. Acetylator genotype-dependent metabolic activation of carcinogenic N-hydroxyarylamines by S-acetyl coenzyme A-dependent enzymes of inbred hamster tissue cytosols: relationship to arylamine N-acetyltransferase.
Hein DW; Flammang TJ; Kirlin WG; Trinidad A; Ogolla F
Carcinogenesis; 1987 Dec; 8(12):1767-74. PubMed ID: 3677303
[TBL] [Abstract][Full Text] [Related]
5. Enzymatic phase II activation of the N-hydroxylamines of IQ, MeIQx and PhIP by various organs of monkeys and rats.
Davis CD; Schut HA; Snyderwine EG
Carcinogenesis; 1993 Oct; 14(10):2091-6. PubMed ID: 8222059
[TBL] [Abstract][Full Text] [Related]
6. Contribution of CYP1A1 and CYP1A2 to the activation of heterocyclic amines in monkeys and human.
Edwards RJ; Murray BP; Murray S; Schulz T; Neubert D; Gant TW; Thorgeirsson SS; Boobis AR; Davies DS
Carcinogenesis; 1994 May; 15(5):829-36. PubMed ID: 8200083
[TBL] [Abstract][Full Text] [Related]
7. Detoxification of carcinogenic aromatic and heterocyclic amines by enzymatic reduction of the N-hydroxy derivative.
King RS; Teitel CH; Shaddock JG; Casciano DA; Kadlubar FF
Cancer Lett; 1999 Sep; 143(2):167-71. PubMed ID: 10503898
[TBL] [Abstract][Full Text] [Related]
8. Acetyl coenzyme A-dependent metabolic activation of N-hydroxy-3,2'-dimethyl-4-aminobiphenyl and several carcinogenic N-hydroxy arylamines in relation to tissue and species differences, other acyl donors, and arylhydroxamic acid-dependent acyltransferases.
Flammang TJ; Kadlubar FF
Carcinogenesis; 1986 Jun; 7(6):919-26. PubMed ID: 3708755
[TBL] [Abstract][Full Text] [Related]
9. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus.
Hein DW; Doll MA; Gray K; Rustan TD; Ferguson RJ
Cancer Res; 1993 Feb; 53(3):509-14. PubMed ID: 8425184
[TBL] [Abstract][Full Text] [Related]
10. Effects of human and rat glutathione S-transferases on the covalent DNA binding of the N-acetoxy derivatives of heterocyclic amine carcinogens in vitro: a possible mechanism of organ specificity in their carcinogenesis.
Lin D; Meyer DJ; Ketterer B; Lang NP; Kadlubar FF
Cancer Res; 1994 Sep; 54(18):4920-6. PubMed ID: 8069858
[TBL] [Abstract][Full Text] [Related]
11. Interindividual variation in the metabolic activation of heterocyclic amines and their N-hydroxy derivatives in primary cultures of human mammary epithelial cells.
Stone EM; Williams JA; Grover PL; Gusterson BA; Phillips DH
Carcinogenesis; 1998 May; 19(5):873-9. PubMed ID: 9635877
[TBL] [Abstract][Full Text] [Related]
12. Metabolic activation of N-hydroxy arylamines and N-hydroxy heterocyclic amines by human sulfotransferase(s).
Chou HC; Lang NP; Kadlubar FF
Cancer Res; 1995 Feb; 55(3):525-9. PubMed ID: 7834621
[TBL] [Abstract][Full Text] [Related]
13. Metabolic activation of heterocyclic amine food mutagens in the mammary gland of lactating Fischer 344 rats.
Davis CD; Ghoshal A; Schut HA; Snyderwine EG
Cancer Lett; 1994 Aug; 84(1):67-73. PubMed ID: 7915639
[TBL] [Abstract][Full Text] [Related]
14. Species differences in the biotransformation of the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by hepatic microsomes and cytosols from humans, rats, and mice.
Lin DX; Lang NP; Kadlubar FF
Drug Metab Dispos; 1995 Apr; 23(4):518-24. PubMed ID: 7600922
[TBL] [Abstract][Full Text] [Related]
15. Mutagenic activation of IQ, PhIP and MeIQx by hepatic microsomes from rat, monkey and man: low mutagenic activation of MeIQx in cynomolgus monkeys in vitro reflects low DNA adduct levels in vivo.
Davis CD; Schut HA; Adamson RH; Thorgeirsson UP; Thorgeirsson SS; Snyderwine EG
Carcinogenesis; 1993 Jan; 14(1):61-5. PubMed ID: 8425272
[TBL] [Abstract][Full Text] [Related]
16. Cytochromes P450 in cynomolgus monkeys mutagenically activate 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) but not 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx).
Sadrieh N; Snyderwine EG
Carcinogenesis; 1995 Jul; 16(7):1549-55. PubMed ID: 7614688
[TBL] [Abstract][Full Text] [Related]
17. Possible relationship between tissue distribution of DNA adducts and genotoxicity of food-derived heterocyclic amines.
Thorgeirsson SS; Davis CD; Schut HA; Adamson RH; Snyderwine EG
Princess Takamatsu Symp; 1995; 23():85-92. PubMed ID: 8844799
[TBL] [Abstract][Full Text] [Related]
18. N-and O-acetylation of aromatic and heterocyclic amine carcinogens by human monomorphic and polymorphic acetyltransferases expressed in COS-1 cells.
Minchin RF; Reeves PT; Teitel CH; McManus ME; Mojarrabi B; Ilett KF; Kadlubar FF
Biochem Biophys Res Commun; 1992 Jun; 185(3):839-44. PubMed ID: 1627140
[TBL] [Abstract][Full Text] [Related]
19. Cytochrome P450 forms in the rodent lung involved in the metabolic activation of food-derived heterocyclic amines.
Hellmold H; Overvik E; Strömstedt M; Gustafsson JA
Carcinogenesis; 1993 Sep; 14(9):1751-7. PubMed ID: 8403195
[TBL] [Abstract][Full Text] [Related]
20. Effect of N-acetyltransferase 2 polymorphism on tumor target tissue DNA adduct levels in rapid and slow acetylator congenic rats administered 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine or 2-amino-3,8-dimethylimidazo-[4,5-f]quinoxaline.
Metry KJ; Neale JR; Bendaly J; Smith NB; Pierce WM; Hein DW
Drug Metab Dispos; 2009 Nov; 37(11):2123-6. PubMed ID: 19666988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
